Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2008-05-06
2008-05-06
Henley, III, Raymond J. (Department: 1614)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S161000, C514S423000, C514S451000, C514S460000
Reexamination Certificate
active
07368469
ABSTRACT:
Use of an inhibitor of the renin-angiotensin system or a pharmaceutically acceptable derivative thereof, optionally together with another antihypertensive, a cholesterol lowering agent, a diuretic or aspirin, in the manufacture of a medicament for the prevention of cardiovascular events; a method of preventing cardiovascular events comprising administering to a patient in need of such prevention an effective amount of an inhibitor of the renin angiotensin system or a pharmaceutically acceptable derivative thereof, optionally together with another antihypertensive, a cholesterol lowering agent, a diuretic or aspirin; and a combination product containing an an inhibitor of the renin-angiotensin system or a pharmaceutically acceptable derivative thereof and a cholesterol lowering agent.
REFERENCES:
patent: 3983140 (1976-09-01), Endo et al.
patent: 4231938 (1980-11-01), Monaghan et al.
patent: 4346227 (1982-08-01), Terahara et al.
patent: 4444784 (1984-04-01), Hoffman et al.
patent: 4448784 (1984-05-01), Glamkowski et al.
patent: 4450171 (1984-05-01), Hoffman et al.
patent: 4587258 (1986-05-01), Gold et al.
patent: 4681893 (1987-07-01), Roth
patent: 4722810 (1988-02-01), Delaney et al.
patent: 4739073 (1988-04-01), Kathawala
patent: 4743450 (1988-05-01), Harris et al.
patent: 4749688 (1988-06-01), Haslanger et al.
patent: 4804770 (1989-02-01), Karanewsky
patent: 4857520 (1989-08-01), Urbach et al.
patent: 4975453 (1990-12-01), Becker et al.
patent: 4983598 (1991-01-01), Cavero et al.
patent: 5061694 (1991-10-01), Aberg et al.
patent: 5098910 (1992-03-01), Becker et al.
patent: 5130333 (1992-07-01), Pan et al.
patent: 5140012 (1992-08-01), McGovern et al.
patent: 5157025 (1992-10-01), Aberg et al.
patent: 5166143 (1992-11-01), Ondetti et al.
patent: 5190970 (1993-03-01), Pan et al.
patent: 5196444 (1993-03-01), Naka et al.
patent: 5202322 (1993-04-01), Allen et al.
patent: 5212165 (1993-05-01), Aberg et al.
patent: 5217958 (1993-06-01), Patel
patent: 5219856 (1993-06-01), Olson
patent: 5223516 (1993-06-01), Delaney et al.
patent: 5225401 (1993-07-01), Seymour
patent: 5231080 (1993-07-01), Schölkens
patent: 5231083 (1993-07-01), Linz et al.
patent: 5266583 (1993-11-01), Ohtawa
patent: 5273995 (1993-12-01), Roth
patent: H1286 (1994-02-01), Eisman et al.
patent: 5298497 (1994-03-01), Tschollar et al.
patent: 5308846 (1994-05-01), Allen et al.
patent: 5362727 (1994-11-01), Robl
patent: 5366973 (1994-11-01), Flynn et al.
patent: 5403856 (1995-04-01), Henning et al.
patent: 5430145 (1995-07-01), Flynn et al.
patent: 5442008 (1995-08-01), Fulberth et al.
patent: 5461039 (1995-10-01), Tschollar et al.
patent: 5470975 (1995-11-01), Atwal
patent: 5500434 (1996-03-01), Becker et al.
patent: 5502199 (1996-03-01), Angerbauer et al.
patent: 5504080 (1996-04-01), Karanewsky
patent: 5506361 (1996-04-01), Koh et al.
patent: 5508272 (1996-04-01), Robl
patent: 5525723 (1996-06-01), Robl
patent: 5552397 (1996-09-01), Karanewsky et al.
patent: 5554624 (1996-09-01), Almansa et al.
patent: 5554625 (1996-09-01), Rivero et al.
patent: 5593971 (1997-01-01), Tschollar et al.
patent: 5612359 (1997-03-01), Murugesan
patent: 5622985 (1997-04-01), Olukotun et al.
patent: 5656603 (1997-08-01), Simmons
patent: 5674893 (1997-10-01), Behounek et al.
patent: 5679671 (1997-10-01), Oinuma et al.
patent: 5684016 (1997-11-01), Henning et al.
patent: 5691375 (1997-11-01), Behounek et al.
patent: 5721244 (1998-02-01), Becker et al.
patent: 5733558 (1998-03-01), Breton et al.
patent: 5744496 (1998-04-01), Henning et al.
patent: 5747504 (1998-05-01), Henning et al.
patent: 5827863 (1998-10-01), Almansa et al.
patent: 5948799 (1999-09-01), Cropp
patent: 5952305 (1999-09-01), Pfeffer et al.
patent: 5972990 (1999-10-01), Pfeffer et al.
patent: 5977160 (1999-11-01), Pfeffer et al.
patent: 6180660 (2001-01-01), Whitney et al.
patent: 2003/0158090 (2003-08-01), Pedersen-Bjergaard et al.
patent: 2005/0065203 (2005-03-01), Yusuf
patent: 2005/0101658 (2005-05-01), Scholkens et al.
patent: 2 026 686 (1991-05-01), None
patent: 2026686 (1991-05-01), None
patent: 2117782 (1993-10-01), None
patent: 2 382 387 (2001-03-01), None
patent: 2 382 549 (2001-03-01), None
patent: 4308504 (1994-09-01), None
patent: 199 13 528 (2000-06-01), None
patent: 0 079 022 (1983-05-01), None
patent: 0 158 927 (1985-10-01), None
patent: 0 241 201 (1987-10-01), None
patent: 0 292 923 (1988-11-01), None
patent: 0 331 014 (1989-09-01), None
patent: 0 363 934 (1990-04-01), None
patent: 0 401 705 (1990-12-01), None
patent: 0 426 066 (1991-05-01), None
patent: 0 457 514 (1991-11-01), None
patent: 0 459 453 (1991-12-01), None
patent: 0 461 548 (1991-12-01), None
patent: 0 474 438 (1992-03-01), None
patent: 0 481 522 (1992-04-01), None
patent: 0 482 498 (1992-04-01), None
patent: 0 508 665 (1992-10-01), None
patent: 0 534 396 (1993-03-01), None
patent: 0 534 492 (1993-03-01), None
patent: 0 540 209 (1993-05-01), None
patent: 0 547 442 (1993-06-01), None
patent: 0 671 170 (1995-09-01), None
patent: 0 671 171 (1995-09-01), None
patent: 0 671 172 (1995-09-01), None
patent: 0 738 510 (1996-10-01), None
patent: 0 738 512 (1996-10-01), None
patent: 0 747 050 (1996-12-01), None
patent: 0 795 327 (1997-09-01), None
patent: 0 317 878 (1999-05-01), None
patent: 1 216 038 (2005-09-01), None
patent: 2 171 103 (1986-08-01), None
patent: 2 308 064 (1997-06-01), None
patent: 10081633 (1998-03-01), None
patent: 1996-7005549 (1996-11-01), None
patent: 9903028-0 (2000-08-01), None
patent: WO 90/05531 (1990-05-01), None
patent: WO 92/10188 (1992-06-01), None
patent: WO 92/19211 (1992-11-01), None
patent: WO 92/20673 (1992-11-01), None
patent: WO 93/17685 (1993-09-01), None
patent: WO 93/20839 (1993-10-01), None
patent: WO 94/07492 (1994-04-01), None
patent: WO 94/11369 (1994-05-01), None
patent: WO 95/13063 (1995-05-01), None
patent: WO/96/07400 (1995-08-01), None
patent: WO 95/26188 (1995-10-01), None
patent: WO 96/07400 (1996-03-01), None
patent: WO 96/24373 (1996-08-01), None
patent: WO 96/40258 (1996-12-01), None
patent: WO 97/27745 (1997-08-01), None
patent: WO 97/49392 (1997-12-01), None
patent: WO 98/30216 (1998-07-01), None
patent: WO 99/09967 (1999-03-01), None
patent: WO 99/11260 (1999-03-01), None
patent: WO 99/20260 (1999-04-01), None
patent: WO 99/44590 (1999-09-01), None
patent: WO 00/02543 (2000-01-01), None
patent: WO 00/18395 (2000-04-01), None
patent: WO 00/45818 (2000-08-01), None
patent: WO 00/67737 (2000-11-01), None
patent: WO 00/71751 (2000-11-01), None
patent: WO 01/11038 (2001-02-01), None
patent: WO 01/15673 (2001-03-01), None
patent: WO 01/15674 (2001-03-01), None
patent: WO 01/15744 (2001-03-01), None
patent: WO 01/76573 (2001-10-01), None
patent: WO 01/76632 (2001-10-01), None
patent: WO 01/78747 (2001-10-01), None
HOPE Study Investigators, “The HOPE (Heart Outcomes Prevention Evaluation) Study: The design of a large simple randomized trial of an angiotensin-converting enzyme inhibitor (ramipril) and vitamin E in patients at high risk of cardiovascular events,” Can. J. Cardiol., vol. 12, No. 2, pp. 127-137 (1996).
Clairmont, “Heart Doc Loses Hope $11M Research Project Ends Early,” Hamilton Spectator newspaper, p. A3, providing a date of May 1999.
Heart Outcomes Prevention Evaluation Study Investigators, “Effects of an Angiotensin-converting-enzyme inhibitor, Ramipril, on cardiovascular events in high-risk patients,” The New England Journal of Medicine, vol. 342, No. 3, pp. 145-153 (2000).
Jeffrey, “New HOPE in heart study,” Medical Post, vol. 35, No. 20, p. 1 (May 1999).
Morrison, Heart Drug Called Major Discovery Ramipril Better Than Aspirin, Fewer Side Effects, Hamilton Spectator newspaper, p. A7, providing a date of May 1999.
News Release, “Hope Study Indicates Ramipril Could Save One Million Lives Each Year”, distributed by PR Newswire Europe Ltd. on behalf of McMaster University health Sciences, providing a date of May 1999.
Leslie Papp, “Aborted vitamin E study will be given second look,” Toronto Star newspaper, p. A5 (May 1999).
Leslie Papp, “Researchers c
Bender Norbert
Dagenais Gilles
Gerstein Hertzel
Rangoonwala Badrudin
Schölkens Bernward
Finnegan Henderson Farabow Garrett & Dunner L.L.P.
Henley III Raymond J.
Sanofi-Aventis Deutschland GmbH
LandOfFree
Use of inhibitors of the renin-angiotensin system in the... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of inhibitors of the renin-angiotensin system in the..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of inhibitors of the renin-angiotensin system in the... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2806394